爱尔眼科(300015) - 2015 Q1 - 季度业绩预告

Financial Performance - The company expects a net profit attributable to shareholders of approximately 81.98 million to 88.53 million CNY, representing a year-on-year increase of 25% to 35%[3] - The estimated impact of non-recurring gains and losses on net profit is approximately -3 million CNY[6] - The performance forecast is based on preliminary calculations by the company's finance department, with detailed financial data to be disclosed in the Q1 2015 report[7] Business Growth - The main business revenue has maintained stable growth due to the increasing brand influence and expanding operational scale[5]